A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT05505825 · COMPLETED
Trial details
- NCT number
- NCT05505825
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2024-07-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.